ATTD Yearbook & More

This category provides fast access to the ATTD Yearbook and useful specialist resources, including media, expert opinion articles, and a range of medical resources.

The ATTD Yearbook addresses a growing interest in the development of new and advanced technologies and devices for the treatment of diabetes which has resulted in numerous manuscripts in medical journals relating to this topic and it summarizes, in a critical way, the most important articles in the field of diabetes technology and treatments.

The 12TH YEARBOOK ON ADVANCED TECHNOLOGIES & TREATMENTS IN DIABETES (ATTD 2020 YEARBOOK) will summarize the most important articles in the field of diabetes technology, published in medical journals during the period between July 2019 to June 2020.  The content of the ATTD 2020 Yearbook will be available free online via the ATTD 2021 website as from the start of the ATTD 2021 meeting. However, if you wish to pre-order a printed copy for EURO 65 you may do it during the registration process.

Mary Ann Liebert, Inc. is the publisher of the ATTD Yearbook and Conference Abstracts.

Please click below to download pdf copies of ATTD Yearbooks from previous years:

ATTD 2019 Yearbook

ATTD 2018 Yearbook

ATTD 2017 Yearbook

ATTD 2016 Yearbook

ATTD 2015 Yearbook 

ATTD 2014 Yearbook 

ATTD 2013 Yearbook

ATTD 2012 Yearbook

ATTD 2011 Yearbook

ATTD 2010 Yearbook

ATTD 2009 Yearbook

The ATTD 2020 Yearbook has been partially supported by:


ATTD International Consensus Meetings on Time in Range (TIR) – BERLIN 2019

Continuous glucose monitoring (CGM) is now increasingly used in routine clinical practice and is gaining appreciation from its users. With its broad use, novel parameters for a better definition of targets for successful metabolic control are available but a consensus between health care professionals and PwD on these parameters is lacking.

In February 2019 the ATTD convened a consensus meeting with an international panel of 30 key opinion leaders in order to establish appropriate settings for a broad and clinically viable consensus on Time in Range (TIR).  These are now summarized in a publication in Diabetes Care.

Diabetes Care 2019; 42:1593-1603

Access the full article on the Diabetes Care website


 ATTD International Consensus on the use of SGLT1&2 inhibitors in treating T1D – ORLANDO 2018

Recent study results show a significant clinical benefit of adjunct therapy with SGLT1&2 inhibitors in addition to insulin in type 1 diabetes. However, this is accompanied by slightly higher DKA rates than placebo in several studies.

In June 2018, the ATTD convened a consensus meeting with an international panel of 30 physicians and researchers with expertise in using SGLT-inhibitor therapy in order to find ways to mitigate DKA and euDKA risk.  These are now summarized in a publication in Diabetes Care.

Diabetes Care 2019; 42:1147-1154

Access the full article on the Diabetes Care website

"Periodically,a new idea, method, or tool leads to a turning point in the Management of diabetes. We believe such a moment is now upon us, brought by the 
development of reliable devices for continuous glucose monitoring (CGM)." 
Editorial by Matthew C. Riddle, Hertzel C. Gerstein, and William T. Cefalu, Diabetes Care 2017;40:1611–1613.

At ATTD 2017, an international panel of physicians, researchers, and individuals with diabetes came together for a consensus meeting and addressed the issues around continuous glucose monitoring (CGM).

Even though CGM moves beyond HbA1c measurement, there are issues such as the lack of standardized metrics for analyzing CGM data, and no clear criteria for matching patients to most appropriate glucose monitoring methodologies.

Consensus recommendations and the current understanding of how CGM results can affect outcomes are now summarizes in a publication in Diabetes Care.

View Summary:

Access the ATTD International Consensus on the Use of Continuous Glucose Monitoring.pdf (PDF)

Access the full article on the Diabetes Care website

ATTD CONSENSUS STATEMENT on the use of Continuous Glucose Monitoring (CGM) in the Pediatric age-group – PARIS 2011

The use of real-time continuous glucose monitoring (CGM) providing continuous glucose measurements became popular and helped PwD to optimize glycemic control and reduce the risk of hypoglycemia.  Yet, the benefits of the current CGM systems have been more challenging to demonstrate, especially in pediatric patients.

In order to address these issues, ATTD, together with the European Society for Pediatric Endocrinology (ESPE), the Pediatric Endocrine Society (PES), and the International Society for Pediatric and Adolescent Diabetes (ISPAD) convened a panel of expert physicians for a consensus conference.

Pediatric Diabetes 2012; 13:215-228

Access the full article on the Pediatric Diabetes website

Consensus Statement on the use of insulin pump therapy in the pediatric age group – BERLIN 2006

The Consensus meeting held in Berlin in April 2006 was organized by the Loop Club, which preceded the ATTD, together with European Society for Pediatric Endocrinology (ESPE), the Lawson Wilkins Pediatric Endocrine Society (LWPES), and the International Society for Pediatric and Adolescent Diabetes (ISPAD) and endorsed by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

A panel of expert physicians discussed the advantages of the use of pump therapy in the pediatric age group.

Diabetes Care 2007; 30:1653-1662

Access the full article on the Diabetes Care website

Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes.
The journal also publishes ADA statements, consensus reports, clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals.
Click here to access the Diabetes Care publication online

DTT logo
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and highlights new pharmacological and device developments to optimize patient care.

Diabetes Technology & Therapeutics is under the editorial leadership of Editor-in-Chief Satish K. Garg, MD, University of Colorado Denver, Barbara Davis Center for Childhood Diabetes; Senior Editors Jay S. Skyler, MD, MACP, University of Miami Miller School of Medicine, and Irl B. Hirsch, MD, University of Washington Medical Center–Roosevelt; and other leading investigators.

Click here to access the online publication

touch endocrinology logo is an independent information resource designed to support physicians, clinicians and related healthcare professionals in continuously developing their knowledge, effectiveness and productivity, with open access articles and multimedia content.

European Endocrinology is a peer-reviewed, open access, bi-annual journal comprising review articles, case reports, practice guides, theoretical discussions, and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of endocrinology.

Click here to access this resource online

HRP Logo

The mission of Hormone Research in Paediatrics is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini-reviews, clinical guidelines and papers on novel insights from clinical practice.

Click here to access this publication online.
Data at the frontiers of diabetes research are collected, systematically organized, and critically evaluated by volumes in this series. Contents are based on recent findings published in the medical literature and reflect the most advanced achievements in current clinical and experimental research on diabetes and allied disorders. By giving these data coherent organization and critical interpretation, the editor and authors of ‘Frontiers in Diabetes’ perform a major service for all scientists conducting experimental or clinical work in the field.
Click here to view the publication online.

Pediatric Diabetes is a bi-monthly journal devoted to disseminating new knowledge relating to the epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes in childhood and adolescence. The aim of the journal is to become the leading vehicle for international dissemination of research and practice relating to diabetes in youth. Papers are considered for publication based on the rigor of scientific approach, novelty, and importance for understanding mechanisms involved in the epidemiology and etiology of this disease, especially its molecular, biochemical and physiological aspects. Work relating to the clinical presentation, course, management and outcome of diabetes, including its physical and emotional sequelae, is considered. In vitro studies using animal or human tissues, whole animal and clinical studies in humans are also considered. The journal reviews full-length papers, preliminary communications with important new information, clinical reports, and reviews of major topics. Invited editorials, commentaries, and perspectives are a regular feature. The editors, based in the USA, Europe, and Australasia, maintain regular communications to assure rapid turnaround time of submitted manuscripts.

Click here to access this publication

The Lancet journals publish original research, reviews, and topical Comment about diabetes, endocrinology, and metabolism. Topics considered by the journal include—but are not limited to—diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.

Click here to access the publication.